Miscellaneous

CWWeekly March 3rd 2008 Issue

Friday, March 7, 2008 11:10 AM

Top News

More... »

EDICT Project Opens Policy Recommendations For Public Comment

Thursday, March 6, 2008 08:20 AM

The EDICT project, short for Eliminating Disparities in Clinical Trials, has invited the public to comment on a series of policy proposals design to help patient recruitment and retention in clinical trials. The period open to public comment runs until March 21.

More... »

AbCRO Opens Two Offices in Russia

Tuesday, March 4, 2008 09:46 AM

Sofia, Bulgaria-based, American-owned contract research organization AbCRO opened two offices in Russia.

More... »

CWWeekly January 25th 2008 Issue

Monday, March 3, 2008 10:05 AM

Top News      

More... »

PharmaNet 2008 Outlook Cut Amid Strong CRO Growth

Friday, February 29, 2008 12:22 PM

Contract research organizations (CROs) had a great run in the past year, but PharmaNet Development Group’s weak guidance for 2008, issued on Feb. 28, sent its shares tumbling more than 30%. That raises concerns about a possible pullback for the clinical trials industry following a strong year.

More... »

GVAX Show Antibody Respone in Prostate Cancer

Wednesday, February 27, 2008 01:34 PM

Cell Genesys reported positive results from a phase II trial of GVAX for the treatment of prostate cancer. GVAX is a cell vaccine that is also being evaluated for the treatment of leukemia and pancreatic cancer.  The autologous vaccine is made by removing a sample of the patient's own tumor and coaxing it into producing granulocyte-macrophage colony stimulating factor (GM-CSF). The vaccine is then re-administered into the patient via injection, which initiates a potent immune response against the tumor.

More... »

Encorium Appoints New CEO, Replaces Borow

Monday, February 25, 2008 11:05 AM

Wayne, Pa.-based Encorium Group has appointed Kai Lindevall, M.D., Ph.D., as chief executive officer, replacing president and CEO, Kenneth Borow, M.D.

More... »

CWWeekly February 18th 2008 Issue

Friday, February 22, 2008 11:47 AM

Top News

More... »

eClinical Technology News

Thursday, February 21, 2008 10:04 AM

• Cleveland, Ohio-based Datatrak inked an enterprise agreement for at least $800,000, depending on the extent of services required by the client. The agreement is a three-year subscription license with an unnamed pharmaceutical company in Europe. The model is a contracting mechanism for the company’s platform is a separate option to its “trial by trial” model. Datatrak stated its typical “revenue composition” has been 25% for the technology element of an eClinical implementation and 75% for services. “We believe that we will always have the trial-by-trial business model, because this is more appropriate for clients with smaller pipelines. However, for clients with more predictable and larger pipelines, this model provides very predictable research and development costs and eliminates wasted time involved with negotiation and contracting under the trial-by-trial mode,” stated Jeffery Green, Pharm.D., chief executive officer of Datatrak.

More... »

Parexel Courts ClinPhone with Takeover Bid

Wednesday, February 20, 2008 10:02 AM

UK-based eClinical company ClinPhone rejected a preliminary takeover offer from Parexel International,  a contract research organization (CRO) based in Waltham, Mass.

More... »